Breaking News

Financial Report: PAREXEL 4Q11

Service revenues up in the quarter and FY11

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

PAREXEL 4Q11 4Q Revenues: $363.2 million (+5%) 4Q Loss: $1.6 million (earnings were $12.9 million 4Q10) FY Revenues: $1.4 billion (+6%) FY Earnings: $48.8 million (+18%) Comments: Consolidated service revenue for the quarter was $232.8 million (+3%) in Clinical Research Services (CRS), $35.2 million (+11%) in PAREXEL Consulting and Medical Communications Services (PCMS), and $42.5 million (+11%) in Perceptive Informatics. New business wins for the quarter were $567.9 million with a book-to-...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters